Recently, a large-scale boolean network model of AML was developed [55]; however, very little work has gone into the development of quantitative molecular-level models of AML [56], and work in this direction has thus far focused only on developing simplistic, small-scale models of the PI3K/AKT pathway in AML [57, 58]. This evidence concerns the gene AKT1 and acute myeloid leukemia.